Profiel
Christine R.
Coyne currently works at Iterum Therapeutics Plc, as Chief Commercial Officer from 2025.
Ms. Coyne also formerly worked at SCYNEXIS, Inc., as Chief Commercial Officer from 2021 to 2022 and Paratek Pharmaceuticals, Inc., as Senior Vice President-Commercial from 2020 to 2021.
Ms. Coyne received her Masters Business Admin degree from Eastern University and undergraduate degree from West Chester University of Pennsylvania.
Actieve functies van Christine Coyne
| Bedrijven | Functie | Begin |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 30-06-2025 |
Eerdere bekende functies van Christine Coyne
| Bedrijven | Functie | Einde |
|---|---|---|
| SCYNEXIS, INC. | Corporate Officer/Principal | 30-11-2022 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2021 |
Opleiding van Christine Coyne
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
SCYNEXIS, Inc.
SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Eastern University
Eastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Chester University of Pennsylvania
West Chester University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Iterum Therapeutics Plc
Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
















